CT7439

· Carrick Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT7439, covering 2025-11-03 to 2025-11-03. Get the full timeline:

Most recent: Clinical Trial Update: A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies [Phase 1, Phase 2]